Clinical, Functional, Immunological and Genetic Factors on the Severity of the Course of Coronavirus Infection
NCT04987853 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2021-08-03
Summary
The purpose of the program. To determine the clinical, functional, immunological, and genetic factors affecting the severity of the course of acute coronavirus infection COVID-19 and PostCovid syndrome, in order to develop management tactics for such patients to reduce the risk of complications and disability.
Conditions
- Covid19
- Corona Virus Infection
Interventions
- DIAGNOSTIC_TEST
-
Clinical and functional analysis
General blood analysis - Complete blood count on an analyzer with differentiation of 5 classes of cells, the ratio of neutrophils to lymphocytes; Blood chemistry - ALT, AST, total bilirubin, direct, LDH, CRP, alpha-amylase, creatinine, urea, glucose, ferritin, glycosylated hemoglobin, vitamin 25 - OH vitamin D, vitamin B12; Coagulogram - D-dimers, fibrinogen, INR, APTT; Other - NT-pro BNP, Homocysteine, IL 6, Troponin, blood group determination; Linked immunosorbent assay - Determination of IgG and IgM antibodies to SARS-CoV-2 coronavirus (COVID-19) in blood serum, RBD; Functional diagnostics • ECG * EchoCG + strain * CT scan of the lungs * Holter * SMAD * Kidney ultrasound * Ultrasound * Doppler ultrasonography of veins and arteries * Chalder Scale, EQ Questionnaire
- DIAGNOSTIC_TEST
-
Neurological analysis
Neurological examination with the isolation of neurological syndromes (motor, cognitive impairments, sleep disorders, asthenic-depressive syndromes, etc.). 2\. Neuropsychological methods - research on the scales of anxiety and depression, MMSE, etc. 3\. Instrumental method - EEG, polysonography, ultrasound of the neck vessels, CT perfusion. 4\. Laboratory research methods: 1. The study of antibodies to some neurospecific antigens - myelin basic protein (MBP), neurospecific enolase (NSE). 2. Study of cellular immunity (CD3 +, CD4 +, CD8 +) and general indicators of humoral immunity (IgG, IgA, IgM, circulating immune complexes).
- DIAGNOSTIC_TEST
-
Immunological analysis:
A comprehensive immunological analysis will be carried out to determine the level of the immune response. Calculation of the level of CD4 +, CD8 + and NK cells. The level of antibodies of the IgG and IgM classes to the proteins of the coronavirus S1, RBD and N was determined
- DIAGNOSTIC_TEST
-
Genetic analysis:
Isolation (extraction) of DNA will be performed from whole blood using commercial kits according to the manufacturer's instructions. To analyze a large number of genetic markers, it is planned to carry out genome-wide sequencing followed by analysis of genetic polymorphisms of candidate genes encoding coronavirus receptors and immunological factors.
Sponsors & Collaborators
-
Nazarbayev University Medical Center
collaborator OTHER -
National Research Center for Cardiac Surgery, Kazakhstan
lead OTHER
Principal Investigators
-
Makhabbat Sansyzbaeva · Chairman of the Board of "National Research Cardiac Surgery Centre" JSC
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-06-01
- Primary Completion
- 2022-12-01
- Completion
- 2023-06-01
Countries
- Kazakhstan
Study Locations
More Related Trials
-
Cardiac Biomarkers for the Quantification of Myocardial Damage After Cardiac Surgery
NCT06066970 ·Status: RECRUITING
-
Impact of Heart Failure Center Program on Cardiac Outcomes in Patients With Heart Failure
NCT01416285 ·Status: COMPLETED
-
Prognostic Factors of Patients Undergoing Redo Cardiac Surgery
NCT03925376 ·Status: UNKNOWN
-
INFLACOR - Clinical and Genetic Predictors of Inflammation Related Complications After Heart Surgery
NCT01020409 ·Status: COMPLETED
-
Mediastinitis and Staphylococcus Aureus
NCT03262558 ·Status: COMPLETED
-
Assessment of Functional Capacity and Inflammatory Markers in Women With Heart Failure With Preserved Ejection Fraction
NCT02649400 ·Status: UNKNOWN
-
Study of the Clinical Scoring System and Cytokines for Prediction of Inflammatory Response in Major Surgery
NCT01353157 ·Status: COMPLETED
-
Strain X Cardiopulmonary Test
NCT02869178 ·Status: UNKNOWN
-
Cardiovascular Consequences After COVID-19
NCT04452630 ·Status: TERMINATED
-
Brain-Induced Neurotrophic Factor Levels in Patients Undergoing Coronary Artery Bypass Surgery
NCT04250935 ·Status: COMPLETED
-
The Prognostic Value of Troponin T for Long-term Outcome After Cardiac Surgery
NCT00468598 ·Status: COMPLETED
-
Myeloid-Derived Supressor Cells in Cardiac Surgery Patients
NCT02902939 ·Status: COMPLETED ·Phase: NA
-
Acute Cardiac Dysfunction in Critical Illnes
NCT05860504 ·Status: RECRUITING
-
Management Practices and the Risk of Infection Following Cardiac Surgery
NCT01089712 ·Status: COMPLETED
-
Evaluation of Respiratory Parameters and Functional Capacity in Coronary Artery Patients
NCT05549739 ·Status: UNKNOWN
-
Serum Catestatin Expression and Cardiometabolic Parameters in Patients With Congestive Heart Failure
NCT03389386 ·Status: COMPLETED
-
Diagnostic and Prognostic Value of Cardiac Biomarkers for Early Coronary Bypass Occlusion in Patients Undergoing Coronary Revascularization
NCT04595630 ·Status: RECRUITING
-
Oxidant-antioxidant Activity, Free Radicle Activity, Immune Response and Biomarkers in Extracorporeal Membrane Oxygenation (ECMO) Patients
NCT01089036 ·Status: UNKNOWN
-
Hemostatic Profile in Patients Affected by COVID-19
NCT04595110 ·Status: UNKNOWN
-
Probiotics and Inflammatory Status in Patients With Heart Failure
NCT03968549 ·Status: UNKNOWN ·Phase: NA
-
Effects of Personality and Context on Recovery From Coronary Artery Bypass
NCT00005334 ·Status: COMPLETED
-
Inflammatory Genetic Polymorphism and Acute Lung Injury After Cardiac Surgery
NCT00826072 ·Status: COMPLETED
-
Predictors of Heart Failure After ST-segment Elevation Myocardial Infarction (HF-EXPRESS)
NCT02650934 ·Status: UNKNOWN
-
Early and Late Complications of COVID-19
NCT05018052 ·Status: UNKNOWN
-
New Biomarkers in Heart- and Renal Failure
NCT02830464 ·Status: COMPLETED